1). Ross J., Grahame R. Joint hypermobility syndrome. BMJ. 2011. 342:c7167.
Article
2). Beridze N., Frishman WH. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications. Cardiol Rev. 2012. 20:4–7.
3). Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007. 2:32.
Article
4). Park JK. Ehlers-Danlos Syndrome type IV and the management of its vascular complication. Korean J Vasc Endovasc Surg. 2011. 27:47–51.
Article
5). Beighton P., de Paepe A., Danks D., Finidori G., Gedde-Dahl T., Goodman R, et al. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet. 1988. 29:581–94.
Article
6). Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998. 77:31–7.
7). Malfait F., Francomano C., Byers P., Belmont J., Berglund B., Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017. 175:8–26.
8). Frank M., Albuisson J., Ranque B., Golmard L., Mazzella JM., Bal-Theoleyre L, et al. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet. 2015. 23:1657–64.
Article
9). Pepin MG., Schwarze U., Rice KM., Liu M., Leistritz D., Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med. 2014. 16:881–8.
Article
10). Yoon YM., Kim DC., Kang MJ. A case of vascular Ehlers-Danlos syndrome with novel mutation c. 2931+2dupT in COL3A1 gene. J Korean Soc Inher Metab Dis. 2014. 14:168–73.
11). Byers PH., Belmont J., Black J., De Backer J., Frank M., Jeunemaitre X, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017. 175:40–7.
Article
12). Murray ML., Pepin M., Peterson S., Byers PH. Pregnancy-related deaths and complications in women with vascular Ehlers-Danlos syndrome. Genet Med. 2014. 16:874–80.
Article
13). Volkov N., Nisenblat V., Ohel G., Gonen R. Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv. 2007. 62:51–7.
Article
14). Lind J., Wallenburg HC. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand. 2002. 81:293–300.
Article
15). Hurst BS., Lange SS., Kullstam SM., Usadi RS., Matthews ML., Marshburn PB, et al. Obstetric and gynecologic challenges in women with Ehlers-Danlos syndrome. Obstet Gynecol. 2014. 123:506–13.
Article
16). Erez Y., Ezra Y., Rojansky N. Ehlers-Danlos type IV in pregnancy. A case report and a literature review. Fetal Diagn Ther. 2008. 23:7–9.
17). Weinbaum PJ., Cassidy SB., Campbell WA., Rickles FR., Vintzileos AM., No-chimson DJ, et al. Pregnancy management and successful outcome of Ehlers-Danlos syndrome type IV. Am J Perinatol. 1987. 4:134–7.
Article
18). Palmquist M., Pappas JG., Petrikovsky B., Blakemore K., Roshan D. Successful pregnancy outcome in Ehlers-Danlos syndrome, vascular type. J Matern Fetal Neonatal Med. 2009. 22:924–7.
Article
19). Okada T., Frank M., Pellerin O., Primio MD., Angelopoulos G., Boughenou MF, et al. Embolization of life-threatening arterial rupture in patients with vascular Ehlers-Danlos syndrome. Cardiovasc Intervent Radiol. 2014. 37:77–84.
Article
20). Baas AF., Spiering W., Moll FL., Page-Christiaens L., Beenakkers IC., Dooijes D, et al. Six uneventful pregnancy outcomes in an extended vascular Ehlers-Danlos syndrome family. Am J Med Genet A. 2017. 173:519–23.
Article